Macrogenics (MGNX) Profit After Tax (QoQ) (2012 - 2026)
Macrogenics (MGNX) Profit After Tax (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Macrogenics | 255.39 Mn | 188.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -159.78% |
| Dec 31, 2025 | -184.15% |
| Sep 30, 2025 | 146.40% |
| Jun 30, 2025 | 11.66% |
| Mar 31, 2025 | -166.28% |
| Dec 31, 2024 | -127.37% |
| Sep 30, 2024 | 201.16% |
| Jun 30, 2024 | -6.66% |
| Mar 31, 2024 | -13.35% |
| Dec 31, 2023 | -361.72% |
| Sep 30, 2023 | -69.39% |
| Jun 30, 2023 | 251.20% |
| Mar 31, 2023 | -396.90% |
| Dec 31, 2022 | 152.04% |
| Sep 30, 2022 | 40.44% |
| Jun 30, 2022 | 37.84% |
| Mar 31, 2022 | -14.40% |
| Dec 31, 2021 | -9.82% |
| Sep 30, 2021 | -32.43% |
| Jun 30, 2021 | 22.11% |